Loading provider…
Loading provider…
Urology Physician in Houston, TX
NPI: 1023428802Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get M.D. Kelly's Phone NumberMobile
Get M.D. Kelly's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2020 - 2027
CA State Medical License
2016 - 2023

American Board of Urology
Urology
University of Texas M D Anderson Cancer Center
Fellowship • Urologic Surgical Oncology
2020 - 2022
University of California (San Diego) Medical Center
Residency • Surgery
2014 - 2019
George Washington University School of Medicine and Health Sciences
smhs.gwu.edu
Medical School
Until 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 57 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 47 | 47 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 46 | 46 |
| 4 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 45 | 59 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 26 | 29 |
Authors: Chengrui Hu, Stephen Williams, Ashish Kamat, Karim Chamie
Journal: JAMA Netw Open
Publication Date: 2022-03-01
Reduced Dose BCG in an Era of BCG Shortage: Real-World Experience from a Tertiary Cancer Centre.
Lead Sponsor: CG Oncology, Inc.
Intervention / Treatment: DRUG: Cretostimogene Grenadenorepvec, OTHER: n-dodecyl-B-D-maltoside
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, DRUG: Gemcitabine, DRUG: Bacillus Calmette Guerin